American Trust - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
American Trust ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,077
-32.2%
23,333
-22.2%
0.00%0.0%
Q2 2023$13,395
-41.0%
30,000
+8.4%
0.00%
-50.0%
Q1 2023$22,686
-47.4%
27,6660.0%0.00%
-50.0%
Q4 2022$43,159
-10.1%
27,6660.0%0.00%0.0%
Q3 2022$48,0000.0%27,6660.0%0.00%0.0%
Q2 2022$48,000
-40.7%
27,666
+22.1%
0.00%
-20.0%
Q1 2022$81,000
-27.0%
22,666
+2.3%
0.01%
-37.5%
Q4 2021$111,00022,1660.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders